Ultragenyx Announces Approval of Crysvita® (burosumab) in Brazil for the Treatment of X-linked Hypophosphatemia (XLH) in Adults and Children March 26, 2019
Akrevia Therapeutics Licenses Exclusive Rights from City of Hope to Expand Development Pipeline of Potent, Tumor Targeted Immunotherapies March 26, 2019
Menlo Therapeutics Announces Publication of Serlopitant Phase 2 Data for the Treatment of Pruritus Associated with Prurigo Nodularis March 25, 2019
Iowa Health Information Network and PatientPing Partner to Power Real-Time Care Coordination Solution March 21, 2019
Notable Health Onboards Resurgens Orthopaedics Physicians Onto Its Artificial Intelligence Wearable Technology Platform After Successful Pilot March 20, 2019
Innovent Announces First Patient Dosed in a Phase IIa Clinical Study of IBI306, an Anti-PCSK9 Monoclonal Antibody March 20, 2019